Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

atoplab.com
 

Enter Stock Symbol:  

Opiant Pharmaceuticals Inc. (OPNT)

17.21 0.14 (0.82%)

10-19 16:00

Open:

16.95

Pre. Close:

17.07

High:

17.431

Low:

16.9255

Volume:

11,317

Market Cap:

65M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

17.453 - 17.523

17.523 - 17.59

Low:

16.756 - 16.833

16.833 - 16.907

Close:

17.086 - 17.207

17.207 - 17.324

Technical analysis  (as of: 2018-10-19 4:37:58 PM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 23.89     One year: 27.25

Support:

Support1: 15.81    Support2: 13.15

Resistance:

Resistance1: 20.46    Resistance2: 23.33

Pivot:

17.33

Moving Averages:

MA(5): 17.03     MA(20): 17.57

MA(100): 16.88     MA(250): 20.99

MACD:

MACD(12,26): -0.68     Signal(12,26,9): -0.64

%K %D:

%K(14,3): 30.07     %D(3): 28.80

RSI:

RSI(14): 42.46

52-Week:

High: 48  Low: 12.75  Change(%): -44.1

Average Vol(K):

3-Month: 6601  10-Days 3682

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
OPNT has closed above bottom band by 44.7%. Bollinger Bands are 53.8% narrower than normal. The narrow width of the bands suggests low volatility as compared to OPNT's normal range. The bands have been in this narrow range for 4 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

2018-10-18T09:38:37-04:00
Opiant Pharmaceuticals' OPNT005 receives grant for development of a heroin vaccine

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology

Shares Out. (M)

3.69

Shares Float (M)

% Held by Insiders

% Held by Institutions

8.00

Shares Short (K)

143

Shares Short Prior Month (K)

Stock Financials

EPS

EPS Est. Current Year

0.500

EPS Est. Next Year

1.250

EPS Est. Next Quarter

Forward EPS

1.#IO

Book Value (p.s.)

7.490

PEG Ratio

Profit Margin

-55.10

Operating Margin

-15.65

Return on Assets (ttm)

-81.6

Return on Equity (ttm)

-159.1

Qtrly Rev. Growth

-17.4

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

Qtrly Earnings Growth

Operating Cash Flow (M)

-2.93

Levered Free Cash Flow (M)

Valuation

P/E

P/E Growth Ratio

P/BV

2.30

P/S

5328913.50

P/CF

-21.67

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2014-12-31

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.